UB Paderborn / Katalog / Suche / in CDI

Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma

The European respiratory journal, 2018-10, Vol.52 (4), p.1800936

2018

Link zum Volltext

Verfügbarkeit prüfen

Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab

Drug safety, 2020-05, Vol.43 (5), p.409-425

2020

Link zum Volltext

Verfügbarkeit prüfen

Rapid onset of effect of benralizumab on morning peak expiratory flow in severe, uncontrolled asthma

Annals of allergy, asthma, & immunology, 2019-05, Vol.122 (5), p.478-485

2019

Link zum Volltext

Verfügbarkeit prüfen

Properdin Contributes to Allergic Airway Inflammation through Local C3a Generation

The Journal of immunology (1950), 2015-08, Vol.195 (3), p.1171-1181

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Benralizumab for Korean Patients With Severe, Uncontrolled Eosinophilic Asthma

Allergy, 2019, Asthma & Immunology Research, 11(4), , pp.508-518

2019

Link zum Volltext

Verfügbarkeit prüfen

The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies

Current medical research and opinion, 2017-09, Vol.33 (9), p.1605-1613

2017

Link zum Volltext

Verfügbarkeit prüfen

Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies

The lancet respiratory medicine, 2018-01, Vol.6 (1), p.51-64

2018

Link zum Volltext

Verfügbarkeit prüfen

Benralizumab efficacy for patients with fixed airflow obstruction and severe, uncontrolled eosinophilic asthma

Annals of allergy, asthma, & immunology, 2020-01, Vol.124 (1), p.79-86

2020

Link zum Volltext

Verfügbarkeit prüfen

Postbronchodilator lung function improvements with benralizumab for patients with severe asthma

Allergy (Copenhagen), 2020-06, Vol.75 (6), p.1507-1510

2020

Link zum Volltext

Verfügbarkeit prüfen

Differential Expression of TRAIL and TRAIL Receptors in Allergic Asthmatics Following Segmental Antigen Challenge: Evidence for a Role of TRAIL in Eosinophil Survival

The Journal of immunology (1950), 2002-11, Vol.169 (10), p.5986-5996

2002

Link zum Volltext

Verfügbarkeit prüfen

Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect on treatment responses

The Journal of asthma, 2014-08, Vol.51 (6), p.603-609

2014

Link zum Volltext

Verfügbarkeit prüfen

Asthmatic Epithelial Cell Proliferation and Stimulation of Collagen Production . Human Asthmatic Epithelial Cells Stimulate Collagen Type III Production by Human Lung Myofibroblasts after Segmental Allergen Challenge

American journal of respiratory and critical care medicine, 2002-01, Vol.165 (2), p.266-272

2002

Link zum Volltext

Verfügbarkeit prüfen

Bid activation during induction of extrinsic and intrinsic apoptosis in eosinophils

Immunology and cell biology, 2007-10, Vol.85 (7), p.518-524

2007

Link zum Volltext

Verfügbarkeit prüfen

Regulation of eosinophil viability by cytokines

American journal of respiratory cell and molecular biology, 2002-04, Vol.26 (4), p.388-390

Zangrilli, James G

2002

Link zum Volltext

Verfügbarkeit prüfen

Distinction between IL‐13+ and IFN‐γ+ natural killer cells and regulation of their pool size by IL‐4

European journal of immunology, 2002-02, Vol.32 (2), p.413-423

2002

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Benralizumab for Korean Patients With Severe, Uncontrolled Eosinophilic Asthma

Allergy, asthma & immunology research, 2022-03, p.508-518

2022

Link zum Volltext

Verfügbarkeit prüfen

Kinetics of IL-10 production after segmental antigen challenge of atopic asthmatic subjects

Journal of allergy and clinical immunology, 2000-11, Vol.106 (5), p.880-886

2000

Link zum Volltext

Verfügbarkeit prüfen

Left ventricular intracardiac metastatic germ cell tumor presenting with hemorrhagic cerebrovascular event

Journal of the American Society of Echocardiography, 2004-10, Vol.17 (10), p.1080-1083

2004

Link zum Volltext

Verfügbarkeit prüfen

Concentration of Cytokines and Growth Factors in BAL Fluid After Allergen Challenge in Asthmatics and Their Effect on α-Smooth Muscle Actin and Collagen III Synthesis by Human Lung Fibroblasts

Chest, 2003-03, Vol.123 (3), p.398S-399S

2003

Link zum Volltext

Verfügbarkeit prüfen

Alterations in vasodilator-stimulated phosphoprotein (VASP) phosphorylation: associations with asthmatic phenotype, airway inflammation and β2-agonist use

Respiratory research, 2006-02, Vol.7 (1), p.25-25, Article 25

2006

Link zum Volltext

Verfügbarkeit prüfen

Properdin contributes to allergic airway inflammation through local C3a generation1

The Journal of immunology (1950), 2015-06, Vol.195 (3), p.1171-1181

2015

Link zum Volltext

Verfügbarkeit prüfen

Atypical mycobacterial osteomyelitis in a non-AIDS patient

Connecticut medicine, 2002-07, Vol.66 (7), p.387

2002

Link zum Volltext

Verfügbarkeit prüfen

Modulation of Vasodilator-Stimulated Phosphoprotein In Vivo in Human Epithelial Cells by Segmental Allergen Challenge and β2-Agonist Therapy

Chest, 2003-03, Vol.123 (3), p.377S-377S

2003

Link zum Volltext

Verfügbarkeit prüfen

Systemic FasL neutralization increases eosinophilic inflammation in a mouse model of asthma

Allergy (Copenhagen), 2012-03, Vol.67 (3), p.328-335

2012

Link zum Volltext

Verfügbarkeit prüfen

TRAIL in the airways

Vitamins and hormones, 2004, Vol.67, p.149

2004

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma

Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab

Rapid onset of effect of benralizumab on morning peak expiratory flow in severe, uncontrolled asthma

Properdin Contributes to Allergic Airway Inflammation through Local C3a Generation

Efficacy and Safety of Benralizumab for Korean Patients With Severe, Uncontrolled Eosinophilic Asthma

The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies

Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies

Benralizumab efficacy for patients with fixed airflow obstruction and severe, uncontrolled eosinophilic asthma

Postbronchodilator lung function improvements with benralizumab for patients with severe asthma

Differential Expression of TRAIL and TRAIL Receptors in Allergic Asthmatics Following Segmental Antigen Challenge: Evidence for a Role of TRAIL in Eosinophil Survival

Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect on treatment responses

Asthmatic Epithelial Cell Proliferation and Stimulation of Collagen Production . Human Asthmatic Epithelial Cells Stimulate Collagen Type III Production by Human Lung Myofibroblasts after Segmental Allergen Challenge

Bid activation during induction of extrinsic and intrinsic apoptosis in eosinophils

Regulation of eosinophil viability by cytokines

Distinction between IL‐13+ and IFN‐γ+ natural killer cells and regulation of their pool size by IL‐4

Efficacy and Safety of Benralizumab for Korean Patients With Severe, Uncontrolled Eosinophilic Asthma

Kinetics of IL-10 production after segmental antigen challenge of atopic asthmatic subjects

Left ventricular intracardiac metastatic germ cell tumor presenting with hemorrhagic cerebrovascular event

Concentration of Cytokines and Growth Factors in BAL Fluid After Allergen Challenge in Asthmatics and Their Effect on α-Smooth Muscle Actin and Collagen III Synthesis by Human Lung Fibroblasts

Alterations in vasodilator-stimulated phosphoprotein (VASP) phosphorylation: associations with asthmatic phenotype, airway inflammation and β2-agonist use

Properdin contributes to allergic airway inflammation through local C3a generation1

Atypical mycobacterial osteomyelitis in a non-AIDS patient

Modulation of Vasodilator-Stimulated Phosphoprotein In Vivo in Human Epithelial Cells by Segmental Allergen Challenge and β2-Agonist Therapy

Systemic FasL neutralization increases eosinophilic inflammation in a mouse model of asthma

TRAIL in the airways

Suchergebnisse filtern